Health Care • Industrial Specialties
$68.41 ▼ -0.56
(-0.81%)
MKT CAP: $2.04B • VOL: 1.04M
52W L $47 52W H $98
ESTA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $211.1M | $166.0M | $165.2M |
| YoY Revenue Growth % | +27.1% | +0.5% | — |
| Gross Profit | $146.3M | $109.5M | — |
| Gross Margin % | 69.3% | 66.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$39.0M | -$50.0M | -$65.0M |
| Operating Margin % | -18.5% | -30.1% | -39.4% |
| Net Income (GAAP) | -$51.1M | -$84.6M | -$78.5M |
| EBITDA (Normalized) | -$34.2M | -$45.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$50.9M | -$58.5M | -$88.5M |
| Capital Expenditures (CapEx) | $6.0M | $6.1M | — |
| Free Cash Flow (FCF) | -$56.9M | -$64.6M | -$88.5M |
| FCF Margin % | -27.0% | -38.9% | -53.6% |
| Return on Invested Capital (ROIC %) | -15.8% | -21.7% | — |
| Cash & Short-Term Equivalents | $75.6M | $90.3M | — |
| Total Debt (Short + Long Term) | $247.5M | $219.6M | — |
| Total Stockholders' Equity | $23.5M | $53.1M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ESTA.